Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:8:323-8.
doi: 10.2147/TCRM.S30139. Epub 2012 Jun 22.

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)

Viroj Wiwanitkit  1
Affiliations

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)

Viroj Wiwanitkit. Ther Clin Risk Manag. 2012.

Abstract

Leishmaniasis is an important vector-borne disease, and it is classified as one of the most important tropical fly-borne infections. This disease can cause two types of clinical manifestations: cutaneous forms and visceral forms. Visceral leishmaniasis, which is also called kala-azar, is a very serious infection that can be fatal. The management of visceral leishmaniasis requires informed diagnostic and therapeutic approaches. Continuous research and development regarding the treatment of visceral leishmaniasis had led to many improvements. Paromomycin is a relatively new antibiotic drug that has been used for the treatment of visceral leishmaniasis for several years. This article reviews and discusses the use of paromomycin for visceral leishmaniasis therapy.

Keywords: leishmaniasis; paromomycin; visceral.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wiwanitkit V, Singh MY. Emerging Infectious Diseases in India. New York: Nova Publisher; 2008.
    1. Wiwanitkit V. Bone marrow leishmaniasis: a review of situation in Thailand. Asian Pac J Trop Med. 2011;4(10):757–759. - PubMed
    1. Antinori S, Schifanella L, Corbellino M. Leishmaniasis: new insights from an old and neglected disease. Eur J Clin Microbiol Infect Dis. 2012;31(2):109–118. - PubMed
    1. Grimaldi G, Jr, Tesh RB, McMahon-Pratt D. A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am J Trop Med Hyg. 1989;41(6):687–725. - PubMed
    1. Grimaldi G, Jr, McMahan-Pratt D. Leishmaniasis and its etiologic agents in the New World: an overview. Prog Clin Parasitol. 1991;2:73–118. - PubMed

LinkOut - more resources